Blood filter during heart surgery may reduce organ damage risk
NCT ID NCT06659289
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 30 times
Summary
This study tested a device called Efferon LPS that filters the blood during heart surgery to remove harmful toxins and reduce the risk of multiple organ failure. It included 14 adults having planned heart surgery with a heart-lung machine. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pavlov First Saint Petersburg State Medical University
Saint Petersburg, Russia
Conditions
Explore the condition pages connected to this study.